![](/img/cover-not-exists.png)
MEK5-ERK5 inhibitors target chronic myeloid leukemia stem cells and in combination with imatinib reduce the expression of stem cell genes
Tusa, I., Cheloni, G., Gray, N.S., Gozzini, A., Sbarba, P. Dello, Rovida, E.Volume:
61
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)61617-9
Date:
July, 2016
File:
PDF, 60 KB
english, 2016